(Q30844126)

27 June 2017

title

The effect of brimonidine tartrate on retinal blood flow in patients with ocular hypertension (English)

1 reference

27 June 2017

main subject

arterial hypertension

1 reference

1 reference

1 reference

Carlsson AM

1

1 reference

27 June 2017

Chauhan BC

series ordinal

2

1 reference

27 June 2017

Lee AA

series ordinal

3

1 reference

27 June 2017

LeBlanc RP

series ordinal

4

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

American Journal of Ophthalmology

27 June 2017

published in

1 reference

27 June 2017

volume

129

1 reference

27 June 2017

issue

3

1 reference

27 June 2017

page(s)

297-301

1 reference

Effects of brimonidine on aqueous humor dynamics in human eyes

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900389-5

A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900389-5

Brimonidine tartrate: a one-month dose response study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900389-5

The role of brimonidine in the treatment of open-angle glaucoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900389-5

The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900389-5

A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. The Brimonidine Study Group III

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900389-5

Glaucoma Hemifield Test. Automated visual field evaluation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900389-5

Two dimensional mapping of the perfusion of the retina and optic nerve head

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900389-5

Laser Doppler flowmetry in the optic nerve

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900389-5

In situ analysis of alpha-adrenoceptors on arteriolar and venular smooth muscle in rat skeletal muscle microcirculation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900389-5

Effect of reduced blood flow on alpha 1- and alpha 2-adrenoceptor constriction of rat skeletal muscle microvessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900389-5

Regulation of retinal and optic nerve blood flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900389-5

Effect of brimonidine tartrate on ocular hemodynamic measurements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900389-5

Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900389-5

Effect of carbogen, oxygen and intraocular pressure on Heidelberg retina flowmeter parameter 'flow' measured at the papilla

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900389-5

Reproducibility and sensitivity of scanning laser Doppler flowmetry during graded changes in PO2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900389-5

Color Doppler imaging and spectral analysis of the optic nerve vasculature in glaucoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900389-5

Color Doppler imaging in patients with asymmetric glaucoma and unilateral visual field loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900389-5

Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: a review of safety, efficacy, dose response, and dosing studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2800%2900389-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9394(00)00389-5

1 reference

27 June 2017

1 reference